FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> layoffs | Millipore

Millipore streamlines, closes plants

As part of a cost-cutting plan that will save $11 million to $15 million a year, Millipore is closing a plant in Lincoln Park, NJ and another in Nodinge, Sweden. The plant closures will be accompanied by 140 job cuts, and Millipore said it may close two more plants in the UK.

The downsizing is the result of falling revenue in the company's bioprocess division, which supplies the drug manufacturing industry and accounts for 40 percent of Millipore's business. After several major acquisitions, Millipore announced last year that it would increase its offering to drug manufacturers.

- see this report for more

Related Articles:
Millipore in $1.6B makeover as life sciences supplier
Millipore to pay $1.4B for Serologicals (April 2006)


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about layoffs   Millipore